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A B S T R A C T 
 
 
 
 
Many reasons for the disparity in survival of 5-7% between rural and urban cancer patients relate to government policies and 
funding issues. However rural healthcare workers, particularly medical practitioners, can make an impact on reducing this disparity 
with attention to factors such as reducing referral processing time, using telemedicine, and ensuring ongoing education of rural 
patients regarding risk factors and screening programs, among other strategies. 
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Introduction 
 
In 2003 the Australian Institute of Health and Welfare and 
the Australasian Association of Cancer Registries reported a 
7% difference in five-year age-adjusted relative survival 
proportions for all cancers between remote centres and larger 
rural and metropolitan centres1. In 2005, the Queensland 
Cancer Registry reported a similar trend2. The reported 
survival for major city, inner regional, outer regional and 
remote centres was 64.7%, 64.9%, 60.8% and 60.1%, 
respectively1.  
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In 2004, the following was summarised for the state of New 
South Wales3: 
 
1. The more remote the area in which a person lives, 
the greater their chance of dying from cancer. 
2. The worst survival figures are in areas where the 
proportion of Indigenous persons is highest. 
3. The survival rates are particularly poor for cervical; 
prostate; head and neck, and colorectal cancers; and 
melanoma. 
 
When survival figures are analysed it is difficult to separate 
the effects of socioeconomic status and Indigenous status on 
survival. These two factors are associated with poorer 
survival1. 
 
This situation is not unique to Australia; the problem is 
shared by the many other developed countries that comprise 
a significant proportion of rural and remote residents4,5. 
There are many possible reasons; however, only a few are 
researched and many remain speculative. In order to devise 
solutions, insight into the known reasons for this disparity is 
essential. 
 
Possible reasons for the rural–urban 
disparity 
 
Possible reasons for the disparity between metropolitan and 
non-metropolitan health outcomes for cancer include 
screening issues, the timing of presentation, delay in referral, 
rural healthcare professional shortages, treatment issues, the 
availability of clinical trials and specialist follow up, GPs’ 
knowledge and the availability of support services. 
 
Screening 
 
Early detection improves survival for most cancers. Contrary 
to popular belief, participation in mammography and Pap 
tests is similar throughout Queensland (pers comm, N Dunn 
[Cancer Screening Services Queensland], 2008).  
For the 24 month period 2005–2006, for mammography the 
participation in the target age group (women 50–69 years) 
was 55.8% in metropolitan areas (Brisbane, Ipswich, Gold 
Coast, Caboolture and Townsville city centres) and 60.9% in 
rural/remote areas (the remainder of the state), according to 
Cancer Screening Services Queensland (pers comm, N 
Dunn, 2008). For Pap tests in 2003–2004 the participation 
rates for the target age group (women 20–69 years) were 
57.7% for metropolitan areas and 57.4% for rural/remote 
areas. 
 
Timing and stage of presentation 
 
Rural and remote patients tend to present with further 
progressed cancer compared with their urban counterparts3. 
It was found in Georgia, USA, that rural residents were twice 
as likely to have unstaged cancers, compared with urban 
residents5. Among patients with known stage at diagnosis, 
rural patients tended to have more advanced disease than 
urban patients. 
 
Delay in referral  
 
A rural Scottish study found significant delay in GP referrals 
reaching specialists6. This could be due to poor 
administrative support, a lack of follow up or human error.  
 
Lack of healthcare providers 
 
There is a shortage of GPs, nurses and allied health 
professionals in non-metropolitan areas. The lack of visiting 
oncologists is another problem, despite the altruism of many 
oncologists who visit rural and regional areas on weekly to 
six-monthly intervals. This is compounded by a difficulty in 
attracting radiation therapists and chemotherapy nurses to 
non-metropolitan areas, which results in patients travelling 
many hours to receive specialist services, potentially 
discouraging early presentation with suspected cancer and 
obtaining timely treatment. 
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Treatment issues 
 
There is no evidence to support or refute the view that rural 
patients are treated later than their urban counterparts. 
However the intensity of treatment may be affected by rural 
residence. 
 
Prostate cancer patients in remote NSW had less radical 
prostatectomies than their urban counterparts and this was 
associated with poorer survival7. There is no evidence that 
rural patients receive less intensive chemotherapy for some 
solid tumours, although this may be suggested anecdotally.  
 
Availability of clinical trials  
 
It is well known that participation in randomised controlled 
trials is associated with improved cancer survival. However, 
many trials demand frequent visits to and investigations by 
specialists. It is conceivable that patients could be excluded 
from trials due to the distance of their residence from the 
trail centre. There is a lack of literature in this area and 
studies are required to explore the impact of this factor. 
 
Follow up 
 
It has been reported that primary health carers may lack the 
knowledge required to deal with the follow-up of leukaemia, 
lymphoma and germ cell tumours, resulting in long travel for 
patients for what may be a brief consultation8. 
 
A significant amount of preparation and organisation is 
needed before rural patients can travel to cities. It is usual for 
specialist review clinic appointments to be cancelled and 
rescheduled multiple times, which may discourage rural 
patients from attending subsequent appointments due to 
difficulties in reorganising work and family commitments.  
 
Decline in cancer education among medical 
schools 
 
Some cancer knowledge is important for all doctors, 
especially those who plan to be work in rural areas, isolated 
from tertiary centres. This is relevant to all aspects of cancer 
care, for instance oral chemotherapeutic agents are used 
increasingly and GPs are asked to take part in patient 
supervision. Despite the need for cancer education, cancer 
knowledge among medical graduates has declined over the 
last 10 years9. Initiatives such as the ‘Ideal Oncology 
Curriculum for Medical Schools’ published by the Clinical 
Oncological Society of Australia10 should be encouraged.  
 
Lack of support services 
 
Travelling to cancer centres requires money, time and family 
support. It has been suggested that having to give up work 
and the resulting financial hardship may discourage rural 
patients from attending regular clinics in major centres. 
Schemes such as Queensland’s Patient Travel Subsidy 
Scheme are very important and a good beginning; however, 
the scheme does not completely cover travel costs11. 
 
Moving forward 
 
Most of the barriers to improving non-metropolitan cancer 
health services are related to government policies and 
funding issues. Discussing these matters is beyond the scope 
of this article. However, leaving the politics and the 
politicians aside, healthcare providers can contribute to 
patient survival through a number of methods. The following 
brief discussion outlines areas where we can make a 
contribution without straining existing or future budgets. 
 
Education  
 
Patient education regarding screening programs and 
prevention initiatives such as ‘Quit Smoking’ campaigns 
should be encouraged to continue. Despite similar 
mammography and Pap test screening rates for rural and 
urban populations, health providers need to continue 
encouraging participation in screening and prevention 
initiatives because improvements can always be made. 
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Reduce referral processing time 
 
One suggested strategy is making routine ‘confirmation of 
receipt’ telephone calls to specialists' rooms to ensure the 
timely arrival of cancer patients' referral letters.  
 
Maintain intensity of treatment 
 
In relation to chemotherapy, rural patients should not receive 
less intensive treatment because of their residential location. 
This treatment can be achieved with the highest degree of 
safety if there is adequate support for rural GPs and their 
patients, for example when patients return home between 
chemotherapy cycles. 
 
Clinical trials 
 
Rural cancer patients should be actively encouraged to 
participate in multinational trials, despite the potential 
increase in workload for their GP, and travel time 
requirements for the patient. 
 
Teaching 
 
Actively teaching and mentoring of medical students in rural 
settings is essential to attract them to eventual rural practice, 
so assisting resolution of doctor shortages in non-
metropolitan regions. 
 
Telemedicine 
 
By using telemedicine facilities, rural patients can have 
immediate access to specialist services without having to 
travel long distances. Chemotherapy can also be supervised 
with the use of this technology. For example, the Townsville 
Hospital Medical Oncologists provide consultation to 
patients in the town of Mt Isa (a mining town approximately 
800 km from Townsville) using videoconferencing. This 
avoids cancer patients in Mt Isa making a 10 hour drive or 
2 hour flight to consult a specialist medical oncologist. The 
telemedicine clinics are conducted weekly, so urgent 
consultations can be arranged and treatment started within a 
week.  
 
This method of service delivery also saves specialists many 
hours of travel time in order to see six to seven patients. 
Mt Isa doctors and nurses also receive one-on-one support 
and education from the Medical Oncologists by telemedicine 
and, most importantly, patients can be treated in their home 
town. A preliminary analysis by the Department of Medical 
Oncology at Townsville Hospital shows that patients are 
mostly satisfied with this service, and that it allows the safe 
delivery of chemotherapy. 
 
Knowledge of services 
 
If GPs have an in-depth knowledge of available rural patient 
support services, patients’ financial and emotional strains 
will be reduced. 
 
Conclusion
 
 
Despite the current literature, all is not bleak. Cancer 
survival is improving over time and the disparity between 
non-metropolitan and metropolitan patients is only 5-7%. 
With ongoing commitment from government and healthcare 
providers at all levels, we can look forward to bridging this 
gap in the future. 
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